Usted buscó: topoisomerase (Maltés - Inglés)

inibizzjoni ta’ topoisomerase ii.
inhibition of topoisomerase ii.

effett antineoplastiku: inibizzjoni ta ’ topoisomerase ii.
antineoplastic effect: inhibition of topoisomerase ii.

dawn l-effetti jistgħu jiġu attribwiti għall-inibizzjoni ta’ topoisomerase ii.
these effects can be attributed to inhibition of topoisomerase ii.

il-miri ewlenin għal pradofloxacin huma l-enzimi batterjali tad-dna gyrase u topoisomerase iv.
the primary targets for pradofloxacin are the bacterial dna gyrase and topoisomerase iv enzymes.

dan jimblokka enzima msejħa topoisomerase i, li hija involuta fid-diviżjoni tad-dna taċ-ċelluli.
it blocks an enzyme called topoisomerase i, which is involved in the division of cell dna.

irinotecan jappartjeni għal grupp ta’ mediċini kontra l-kanċer imsejħa 'inibituri ta’ topoisomerase'.
irinotecan belongs to a group of cancer medicines called ‘topoisomerase inhibitors’.

l-attività ta’ topotecan kontra tumuri tikkonsisti fl-inibizzjoni ta’ topoisomerase-i, li hija enżima partikolarment involuta fir-replikazzjoni ta’ dna waqt li jneħħi l-istrejn tat-tidwir ta’ qabel il-moving replication fork.
the anti-tumour activity of topotecan involves the inhibition of topoisomerase-i, an enzyme intimately involved in dna replication as it relieves the torsional strain introduced ahead of the moving replication fork.